This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

    More

    Page   1/4   
  • Health care current: August 19, 2014
    This weekly series explores breaking news and developments in the U.S. health care industry, examines key issues facing life sciences and health care companies and provides updates and insights on policy, regulatory and legislative changes.
  • 3 video insights: Innovative challenges for the Modern CIO
    Discover unique perspectives and explore leading practices through a series of interviews with Deloitte’s key industry leaders and subject matter experts. Gain insights on the application of mHealth, the comparative and predictive nature of analytics, the advantages of disruptive technologies, M&A and the evolving role of the CIO.
  • Young adults and health insurance: Not invincible — but perhaps convincible
    Looking ahead to the next open enrollment season, how can health plans and government agencies entice young people to participate? According to Deloitte’s 2014 Survey of Young Adults and Health Insurance, the answer may lie in information, affordability, and value.
  • Good for what ails us: The disruptive rise of value-based care
    The health care industry is ripe for disruptive innovation as systemic challenges continue to face the industry and stakeholders demand increased value. Health care stakeholders will need to change traditional delivery and payment models or risk survival.
  • In the face of uncertainty - Redefining biopharma innovation
    A recent Deloitte study has shown that the overall rate of return on R&D investment for the 12 largest biopharmaceutical firms has dropped significantly since 2010, and the cost of developing a new medicine has risen substantially. Learn more.
  • Home health care: New opportunities and challenges for care provided inside the home
    The demand for efficient home health care is projected to grow, particularly amid the adoption of new and expanded payment and delivery models. Industry stakeholders interested in home health will need to carefully navigate this new landscape.
  • Infographic: No time to slow down: Looking ahead to 2015 HIX open enrollment
    The 2014 HIX open enrollment season is now over, and the first round of results are in. Initial estimates as of April 19, 2014, suggest that more than 8 million individuals are now enrolled in health insurance coverage through the federally-facilitated or state-based HIXs. What’s behind the numbers? And what uncertainties could the industry face as stakeholders begin placing bets for 2015 HIX open enrollment and beyond?
  • The four dimensions of effective mHealth: People, places, payment and purpose
    The promise of mHealth is profound but, as yet, unrealized. While the tools to deliver mHealth already reside in users’ hands, how do we bridge the gap from opportunity to adoption? In order for mHealth to reach its full potential, four critical dimensions must align: people, places, payment and purpose.
  • The quest for value in health care: A place for consumers
    Three key disrupters are driving an increasingly consumer-centric health care system. How are consumers responding? What are the implications for the industry? And what steps can health care providers, health plans and life sciences companies consider to help win in this new marketplace?
  • Health care reform: Redefining biopharma innovation
    Health care reform encompasses legislation that has been signed in the recent past related to the access and delivery of healthcare, notably the Affordable Care Act (ACA) passed in 2010, as well as broader, nonreversible trends in the market. Reform culminates into a heightened focus on reducing cost while increasing the quality of care, which will likely force a new definition of innovation to emerge for biopharma.
  • Page   1/4